- Home
- Mutual Funds
- Mirae Asset Mutual Fund
- Mirae Asset Healthcare Fund Direct-idcw
Fund Overview of Mirae Asset Healthcare Fund Direct-idcw
-
₹3,090.5 CrAUM
-
₹28.45NAV
-
0.62%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Mirae Asset Healthcare Fund Direct-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 9.54% | NA | 6.12% |
| 6 Months | 11.17% | NA | 12.92% |
| 1 Year | 13.22% | 13.22% | 6.04% |
| 2 Years | 30.68% | 14.32% | 24.93% |
| 3 Years | 94.74% | 24.88% | 25.71% |
| 5 Years | 107.62% | 15.73% | 19.91% |
| 7 Years | 371.97% | 24.82% | NA |
Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision
Compare Mirae Asset Healthcare Fund Direct-idcw with other mutual funds in the same category
Mirae Asset Healthcare Fund Direct-idcw
SBI Healthcare Opportunities Fund Direct Plan-growth
SBI Healthcare Opportunities Fund Direct Plan-idcw
Asset Allocation
equities
99.36%debt instruments
0.01%other assets or cash equivalents
0.64%Mirae Asset Healthcare Fund Direct-idcw is one Equity mutual fund offered by Mirae Asset Mutual Fund. Launched on 02 Jul 2018, the fund aims To generate long term capital appreciation. Investments in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. It manages assets worth ₹3,090.5 crore as on Sun May 31, 2026. The expense ratio stands at 0.62%. Fund Manager Manager Education Fund Manager Manager EducationAbout Mirae Asset Healthcare Fund Direct-idcw
The portfolio allocation consists of 99.36% in equities, 0.01% in debt instruments, 0.64% in other assets or cash equivalents.Managed by Vrijesh Kasera, it has delivered a return of 13.22% in the last year, a total return since inception of 21.53%.
The latest dividend was declared on 28 Jan 2026 at 22.10% of face value.
While exploring investment options long-term planners also look at best sip in india depending on investment horizon.
Key Metrics of Mirae Asset Healthcare Fund Direct-idcw
-
Standard Deviation16.89%
-
Sharpe Ratio1.16%
-
Alpha1.00%
-
Beta0.97%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
SBI Healthcare Opportunities Fund Direct Plan-growth  |
₹4,566 | 1.67% | 13.30% | 10.49% | 24.74% | 16.80% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,566 | 1.67% | 13.30% | 10.49% | 24.74% | 16.80% |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth  |
₹6,454 | -1.21% | 11.20% | 7.32% | 26.34% | 16.48% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | -1.21% | 11.20% | 7.32% | 26.34% | 16.48% |
| Mirae Asset Healthcare Fund Direct-growth |
₹3,091 | -0.79% | 9.54% | 13.22% | 24.88% | 15.73% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹3,091 | -0.79% | 9.54% | 13.22% | 24.88% | 15.73% |
| DSP Healthcare Fund Direct-growth |
₹3,309 | 3.03% | 14.21% | 8.50% | 22.68% | 15.62% |
| DSP Healthcare Fund Direct-idcw |
₹3,309 | 3.03% | 14.21% | 8.50% | 22.68% | 15.62% |
| SBI Healthcare Opportunities Fund-growth |
₹4,566 | 1.58% | 13.02% | 9.38% | 23.45% | 15.57% |
| SBI Healthcare Opportunities Fund-idcw |
₹4,566 | 1.58% | 13.02% | 9.38% | 23.45% | 15.57% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More funds from Mirae Asset Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Mirae Asset Healthcare Fund Regular-growth
|
₹3,091 | -0.92% | 9.14% | 10.37% | 11.60% | 23.07% |
|
Mirae Asset Healthcare Fund Direct-growth
|
₹3,091 | -0.79% | 9.54% | 11.17% | 13.22% | 24.88% |
|
Mirae Asset Healthcare Fund Regular-idcw
|
₹3,091 | -0.92% | 9.14% | 10.37% | 11.60% | 23.07% |
|
Mirae Asset Nifty 500 Healthcare Etf-growth
|
₹12 | -0.92% | 9.69% | - | - | - |
growth is based on 1-month returns of the fundsMutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹8,636 | ₹535.25 | 20.43% | 12.64% | 15.21% |
| Nippon India Pharma Fund Direct-growth |
₹8,636 | ₹601.05 | 21.51% | 13.66% | 16.24% |
| Nippon India Pharma Fund-idcw |
₹8,636 | ₹115.58 | 20.43% | 12.64% | 15.21% |
| Nippon India Pharma Fund Direct-idcw |
₹8,636 | ₹164.49 | 21.51% | 13.66% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,454 | ₹41.36 | 25.28% | 15.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,454 | ₹44.89 | 26.34% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,454 | ₹24.13 | 25.28% | 15.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | ₹27.11 | 26.34% | 16.48% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,566 | ₹468.57 | 23.45% | 15.57% | 13.35% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,566 | ₹541.52 | 24.74% | 16.80% | 14.59% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.13% | ₹344.03 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.03% | ₹248.13 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 6.45% | ₹199.26 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.40% | ₹197.78 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 6.04% | ₹186.67 Cr |
| Laurus Labs Ltd | Healthcare | 4.35% | ₹134.53 Cr |
| Lupin Ltd | Healthcare | 4.28% | ₹132.13 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 4.27% | ₹131.94 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.12% | ₹127.28 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.88% | ₹120.06 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.57% | ₹110.45 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.55% | ₹109.67 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 3.26% | ₹100.60 Cr |
| Eris Lifesciences Ltd | Healthcare | 3.25% | ₹100.35 Cr |
| Sai Life Sciences Ltd. | Healthcare | 3.23% | ₹99.68 Cr |
| Cipla Ltd | Healthcare | 3.21% | ₹99.28 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.10% | ₹95.73 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.02% | ₹93.35 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.54% | ₹78.52 Cr |
| Max Healthcare Institute Ltd | Healthcare | 2.35% | ₹72.53 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹541.52 | 24.74% | 16.80% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹376.23 | 24.74% | 16.80% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹44.89 | 26.34% | 16.48% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.11 | 26.34% | 16.48% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.24 | 24.88% | 15.73% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.45 | 24.88% | 15.73% | - |
| DSP Healthcare Fund Direct-growth |
₹46.19 | 22.68% | 15.62% | - |
| DSP Healthcare Fund Direct-idcw |
₹26.71 | 22.68% | 15.62% | - |
| SBI Healthcare Opportunities Fund-growth |
₹468.57 | 23.45% | 15.57% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹295.17 | 23.45% | 15.57% | - |
growth is based on 5Y returns of the funds
Frequently Asked Questions
Mirae Asset Healthcare Fund Direct-idcw
What is the current AUM of Mirae Asset Healthcare Fund Direct-idcw?
As of Sun May 31, 2026, Mirae Asset Healthcare Fund Direct-idcw manages assets worth ₹3,090.5 crore
How has Mirae Asset Healthcare Fund Direct-idcw performed recently?
- 3 Months: 9.54%
- 6 Months: 11.17%
What is the long-term performance of Mirae Asset Healthcare Fund Direct-idcw?
- 3 Years CAGR: 24.88%
- 5 Years CAGR: 15.73%
- Since Inception: 21.53%
What is the portfolio composition of Mirae Asset Healthcare Fund Direct-idcw?
Equity: 99.36%, Debt: 0.01%, Others: 0.64%.
Who manages Mirae Asset Healthcare Fund Direct-idcw?
Mirae Asset Healthcare Fund Direct-idcw is managed by Vrijesh Kasera from Mirae Asset Mutual Fund.
When was the last dividend declared by Mirae Asset Healthcare Fund Direct-idcw?
Latest dividend was declared on 28 Jan 2026 at 22.10% of face value.
What is the market-cap allocation of Mirae Asset Healthcare Fund Direct-idcw?
Large Cap: 35.72%, Mid Cap: 35.02%, Small Cap: 29.26%.
Which are the top companies Mirae Asset Healthcare Fund Direct-idcw has invested in?
- Sun Pharmaceutical Industries Ltd – 11.13% of the fund's portfolio
- Divi's Laboratories Ltd – 8.03% of the fund's portfolio
- JB Chemicals & Pharmaceuticals Ltd – 6.45% of the fund's portfolio
- Glenmark Pharmaceuticals Ltd – 6.40% of the fund's portfolio
- Apollo Hospitals Enterprise Ltd – 6.04% of the fund's portfolio
Which are the major sectors Mirae Asset Healthcare Fund Direct-idcw focuses on?
- Healthcare – 90.02% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.
